The DCT OS Report: More than 95% of biopharma executives say we're not going back to a site-based-only development model. Learn more

News

Science 37<sup>®</sup> and Advarra Detail Methods for Research Continuity
Science 37® and Advarra Detail Methods for Research Continuity

A new whitepaper from Science 37 and Advarra explores how research is continuing in the COVID-19 era.   Although many nations appear to have turned the tide in the current global pandemic, the...

CONTINUE
Science 37<sup>®</sup> Furthers Global Expansion and Decentralized Trial Leadership
Science 37® Furthers Global Expansion and Decentralized Trial Leadership

Science 37 adds to its industry-leading virtual trial capabilities in Europe, South America, and Asia-Pacific.-- LOS ANGELES, July 28, 2020 - Science 37, the industry leader in decentralized clinic...

CONTINUE
Science 37<sup>®</sup> Appoints Mike Zaranek as Chief Financial Officer
Science 37® Appoints Mike Zaranek as Chief Financial Officer

Executive role applies financial rigor to ensure profitable growth as the company continues to scale. LOS ANGELES, May 19, 2020 - Science 37, the industry leader in virtual clinical trials, announc...

CONTINUE
Science 37<sup>®</sup> and AiCure Partner to Enhance Virtual Clinical Trials
Science 37® and AiCure Partner to Enhance Virtual Clinical Trials

The partnership combines artificial intelligence with comprehensive virtual trial services to bring novel insights to research. LOS ANGELES & NEW YORK, April 30, 2020 - Science 37, the industry...

CONTINUE
Science 37<sup>®</sup> Partners with Advarra to Expedite Virtual Trial Research for COVID-19
Science 37® Partners with Advarra to Expedite Virtual Trial Research for COVID-19

The partnership addresses key concerns for clinical trial sponsors as they transition to virtual trials in light of the COVID-19 pandemic.-- LOS ANGELES & COLUMBIA, Md., April 21, 2020 - Scienc...

CONTINUE
Rapid-Start COVID-19 Studies Delivered through Science 37<sup>®</sup> and Innovo Partnership
Rapid-Start COVID-19 Studies Delivered through Science 37® and Innovo Partnership

Rapid-Start COVID-19 Studies Delivered through Science 37 and Innovo Partnership   The new partnership will help accelerate the start-up time for clinical trials related to the COVID-19 pandem...

CONTINUE
Navigating Clinical Trials in the Coronavirus Era
Navigating Clinical Trials in the Coronavirus Era

The report explores approaches for sponsors to mitigate risks to patient safety and business continuity in clinical trials - both immediately and moving forward.   LOS ANGELES, March 12, 2020 ...

CONTINUE
Science 37<sup>®</sup> Strengthens Operational Efficiencies with EDC Integration
Science 37® Strengthens Operational Efficiencies with EDC Integration

The fully integrated mobile enhancement provides a real-time window into trial operations -- LOS ANGELES, February 18, 2020 - Science 37, the industry leader in decentralized clinical trials, has l...

CONTINUE
Science 37<sup>®</sup> Enhances Its Patient Experience and Introduces Native Support for iOS and Android
Science 37® Enhances Its Patient Experience and Introduces Native Support for iOS and Android

The fully integrated mobile enhancement provides a real-time window into trial operations† LOS ANGELES, February 18, 2020 Science 37, the industry leader in decentralized clinical trials, ha...

CONTINUE
Science 37<sup>®</sup> Extends Market-Leading Capabilities in Decentralized Clinical Trial Execution
Science 37® Extends Market-Leading Capabilities in Decentralized Clinical Trial Execution

New additions to the Science 37 executive team will enhance both the patient and sponsor experiences as well as extend patient recruitment and trial execution efficiencies -- LOS ANGELES, January 1...

CONTINUE
Science 37<sup>®</sup> Appoints Steven Geffon as Chief Commercial Officer
Science 37® Appoints Steven Geffon as Chief Commercial Officer

Executive role will significantly scale commercial operations and create unparalleled value for clients -- LOS ANGELES, December 17, 2019 - Science 37, the industry leader in decentralized clinical...

CONTINUE
Science 37<sup>®</sup> Names David Coman Chief Executive Officer
Science 37® Names David Coman Chief Executive Officer

Organization extends its market leadership in the decentralized clinical trial industry LOS ANGELES, November 21, 2019 - Science 37, the industry leader in decentralized clinical trials, announced ...

CONTINUE
Page 2 of 3
123